SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-006518
Filing Date
2015-08-07
Accepted
2015-08-06 18:24:51
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q atra-10q_20150630.htm 10-Q 1929921
2 EX-10.32 atra-ex1032_525.htm EX-10.32 583285
3 EX-31.1 atra-ex311_8.htm EX-31.1 12575
4 EX-31.2 atra-ex312_6.htm EX-31.2 12599
5 EX-32.1 atra-ex321_9.htm EX-32.1 7526
6 GRAPHIC g20150806214815658902.jpg GRAPHIC 3250
  Complete submission text file 0001564590-15-006518.txt   6888290

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT atra-20150630.xml EX-101.INS 1461730
8 XBRL TAXONOMY EXTENSION SCHEMA atra-20150630.xsd EX-101.SCH 30541
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atra-20150630_cal.xml EX-101.CAL 36489
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atra-20150630_def.xml EX-101.DEF 128799
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE atra-20150630_lab.xml EX-101.LAB 295632
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atra-20150630_pre.xml EX-101.PRE 218947
Mailing Address 3260 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3260 BAYSHORE BOULEVARD BRISBANE CA 94005 415-287-2410
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36548 | Film No.: 151034528
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences